KnowledgeBase

• Home
• Antimicrobials
• Microorganisms
• About Us
• Contact Us

• Search All
• Search by Antimicrobial
• Search by Microorganism
• 

Home › Search by Microorganism › Streptococcus (α-haemolytics + 32213-7)

• Streptococcus
• Streptococcus (15876)
• Streptococcus (3476)
• Streptococcus (ATCC 49399 + group A)
• Streptococcus (B 209)
• Streptococcus (B 52)
• Streptococcus (erythromycin-resistant)
• Streptococcus (group A)
• Streptococcus (group B)
• Streptococcus (Group C + clinical isolate)
• Streptococcus (group C + erythromycin-susceptible)
• Streptococcus (Group C + macrolide-resistant + clinical isolate)
• Streptococcus (group C + mef(A))
• Streptococcus (group C)
• Streptococcus (group D)
• Streptococcus (group F)
• Streptococcus (Group G + clinical isolate)
• Streptococcus (group G + erythromycin-susceptible)
• Streptococcus (group G + inducible erm(TR))
• Streptococcus (group G isolate)
• Streptococcus (Group G + macrolide-resistant + clinical isolate)
• Streptococcus (group G)
• Streptococcus (pH 5.2-5.6)
• Streptococcus (α-haemolytics + 32213-7)
• Streptococcus (β-haemolytics + 32210-20)
• Streptococcus (β-hemolytic)

This project is supported by TOKU-E which specializes in manufacturing ultra-pure antibiotics for a broad spectrum of biotechnology applications as well as for the pharmaceutical industry. TOKU-E is a global leader in biotechnology innovation, offering great benefits and applications to the biopharmaceutical and diagnostic industries as well as for biotechnology research communities.
Privacy Policy | Terms of Use
Knowledgebase version 1.8